Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy
Open Access
- 15 June 2021
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 19 (1) , 1-21
Abstract
Gestational trophoblastic tumors seriously endanger child productive needs and the health of women in childbearing age. Nanodrug-based therapy mediated by transporters provides a novel strategy for the treatment of trophoblastic tumors. Focusing on the overexpression of human equilibrative nucleoside transporter 1 (ENT1) on the membrane of choriocarcinoma cells (JEG-3), cytarabine (Cy, a substrate of ENT1)-grafted liposomes (Cy-Lipo) were introduced for the targeted delivery of methotrexate (Cy-Lipo@MTX) for choriocarcinoma therapy in this study. ENT1 has a high affinity for Cy-Lipo and can mediate the endocytosis of the designed nanovehicles into JEG-3 cells. The ENT1 protein maintains its transportation function through circulation and regeneration during endocytosis. Therefore, Cy-Lipo-based formulations showed high tumor accumulation and retention in biodistribution studies. More importantly, the designed DSPE-PEG2k-Cy conjugation exhibited a synergistic therapeutic effect on choriocarcinoma. Finally, Cy-Lipo@MTX exerted an extremely powerful anti-choriocarcinoma effect with fewer side effects. This study suggests that the overexpressed ENT1 on choriocarcinoma cells holds great potential as a high-efficiency target for the rational design of active targeting nanotherapeutics.Graphic abstractKeywords
Funding Information
- National Natural Science Foundation of China (81873838)
- Natural Science Foundation of Zhejiang Province (LGF21H160023, LQ20H300002)
This publication has 53 references indexed in Scilit:
- Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene DeliveryAdvanced Materials, 2011
- Triggered Release of Pharmacophores from [Ni(HAsO3)]-Loaded Polymer-Caged Nanobin Enhances Pro-apoptotic Activity: A Combined Experimental and Theoretical StudyACS Nano, 2011
- Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasiaAmerican Journal of Obstetrics and Gynecology, 2011
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends in Pharmacological Sciences, 2009
- Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targetsThe Lancet Oncology, 2007
- Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1Pharmacogenetics and Genomics, 2006
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Gene-Expression Profiling Reveals Down-Regulation of Equilibrative Nucleoside Transporter 1 (ENT1) in Ara-C-Resistant CCRF-CEM-Derived CellsThe Journal of Biochemistry, 2004
- Methotrexate pneumonitis after systemic treatment for ectopic pregnancyAmerican Journal of Obstetrics and Gynecology, 1997
- Ethanol and Mitotic Inhibitors Promote Differentiation of Trophoblastic CellsAlcohol, Clinical and Experimental Research, 1996